These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27125084)

  • 21. Prediction of proliferative vitreoretinopathy after retinal detachment surgery: potential of biomarker profiling.
    Ricker LJ; Kessels AG; de Jager W; Hendrikse F; Kijlstra A; la Heij EC
    Am J Ophthalmol; 2012 Aug; 154(2):347-354.e2. PubMed ID: 22541653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative vitreoretinopathy.
    Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
    Am J Ophthalmol; 1999 Dec; 128(6):763-5. PubMed ID: 10612518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct Serum and Vitreous Inflammation-Related Factor Profiles in Patients with Proliferative Vitreoretinopathy.
    Ni Y; Qin Y; Huang Z; Liu F; Zhang S; Zhang Z
    Adv Ther; 2020 May; 37(5):2550-2559. PubMed ID: 32274748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy.
    Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
    Am J Ophthalmol; 2000 May; 129(5):678-80. PubMed ID: 10844070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating the pathological processes of rhegmatogenous retinal detachment and proliferative vitreoretinopathy with metabolomics analysis.
    Li M; Li H; Jiang P; Liu X; Xu D; Wang F
    Mol Biosyst; 2014 May; 10(5):1055-62. PubMed ID: 24556753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
    Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Chemokine CXCL-1 and Interleukin-6 Concentrations in the Subretinal Fluid and Vitreous in Rhegmatogenous Retinal Detachment.
    Symeonidis C; Rotsos T; Matsou A; Dermenoudi M; Georgalas I; Tsinopoulos I; Makri O; Souliou E; Dimitrakos SA
    Ocul Immunol Inflamm; 2021 Feb; 29(2):355-361. PubMed ID: 31661651
    [No Abstract]   [Full Text] [Related]  

  • 28. Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
    Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M
    Am J Ophthalmol; 2002 Jun; 133(6):851-2. PubMed ID: 12036691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levels of Anti-Retinal Antibodies in Retinal Detachment and Proliferative Vitreoretinopathy.
    Ichinohasama R; Nishiguchi KM; Fujita K; Aizawa N; Inoue T; Sasaki E; Kunikata H; Nakazawa T
    Curr Eye Res; 2018 Jun; 43(6):804-809. PubMed ID: 29547015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of transforming growth factor β-1 vitreous levels with clinical severity of proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment.
    Palomares-Ordóñez JL; Sánchez-Ramos JA; Ramírez-Estudillo JA; Robles-Contreras A
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Jan; 94(1):12-17. PubMed ID: 30309666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of interleukin-6 and matrix metalloproteinase expression in the subretinal fluid and the vitreous during proliferative vitreoretinopathy: correlations with extent, duration of RRD and PVR grade.
    Symeonidis C; Papakonstantinou E; Androudi S; Georgalas I; Rotsos T; Karakiulakis G; Diza E; Dimitrakos SA
    Cytokine; 2014 Jun; 67(2):71-6. PubMed ID: 24725542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitreous levels of apolipoprotein A1 and retinol binding protein 4 in human rhegmatogenous retinal detachment associated with choroidal detachment.
    Ding N; Luo S; Yu J; Zhou Y; Wu Z
    Mol Vis; 2018; 24():252-260. PubMed ID: 29618920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surface Area of Detachment, Proliferative Vitreoretinopathy, and Pulse Pressure, but not AGEs, are Associated With Retinal Redetachment.
    Fokkens BT; Mulder DJ; Nugteren MB; Schalkwijk CG; Scheijen JL; Smit AJ; Los LI
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6633-6638. PubMed ID: 27926755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tenascin-C levels in the vitreous of patients with proliferative vitreoretinopathy.
    Mitamura Y; Takeuchi S; Ohtsuka K; Matsuda A; Yamamoto T; Yamamoto S; Hiraiwa N; Kusakabe M
    Ophthalmologica; 2003; 217(6):422-5. PubMed ID: 14573976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in vitreous fluid from eyes with retinal detachment complicated by proliferative vitreoretinopathy.
    La Heij EC; van de Waarenburg MP; Blaauwgeers HG; Kessels AG; Liem AT; Theunissen C; Steinbusch H; Hendrikse F
    Am J Ophthalmol; 2002 Sep; 134(3):367-75. PubMed ID: 12208248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining the seriousness of proliferative vitreoretinopathy by aspiration of cytokines from the anterior chamber.
    Rusnak S; Vrzalova J; Hecová L; Kozova M; Topolcan O; Ricarova R
    Biomark Med; 2013 Oct; 7(5):759-67. PubMed ID: 24044568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elucidation of the pathogenic mechanism of rhegmatogenous retinal detachment with proliferative vitreoretinopathy by proteomic analysis.
    Yu J; Peng R; Chen H; Cui C; Ba J
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8146-53. PubMed ID: 23139279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Elner SG; Elner VM; Jaffe GJ; Stuart A; Kunkel SL; Strieter RM
    Curr Eye Res; 1995 Nov; 14(11):1045-53. PubMed ID: 8585935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders.
    Abu el-Asrar AM; Van Damme J; Put W; Veckeneer M; Dralands L; Billiau A; Missotten L
    Am J Ophthalmol; 1997 May; 123(5):599-606. PubMed ID: 9152065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.